- American City Business Journals•27 days ago
Medtronic has reached a deal to buy heart-failure device maker HeartWare International Inc. in a deal worth about $1.1 billion, the company announced Monday. Framingham, Mass.-based HeartWare (HTWR) makes a mechanical pump called HVAD that's implanted in people with advanced heart failure caused by one ventricle of the heart not working properly. Medtronic will pay $58 per share for HeartWare.That purchase price marks a 93 percent premium over HeartWare's closing stock price Friday.
- 24/7 Wall St.•27 days ago
Heartware International (NASDAQ: HTWR) is watching its shares absolutely skyrocket in Monday’s session despite the huge market downturn from the Brexit. This surge is the result of Medtronic PLC (NYSE: ...
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|52wk Range||undefined - undefined|
|Day's Range||N/A - N/A|
|Avg Vol (3m)||N/A|